“Just Scanning Around” with Diagnostic Medical Ultrasound: Should
States Regulate the Non-Diagnostic Uses of This Technology?
I. Introduction.
Yes, America has become the land of medical imaging opportunity, where anyone
can participate in the ultrasound imaging experience. Perhaps, the actor Tom Cruise
reached the pinnacle of the self-referral imaging indulgence, when he revealed to Barbara
Walters and her national television audience that he had recently purchased his very own
ultrasound system.1 He told his listening audience that he was able to scan his baby-to-be
at anytime, but he had not yet learned its sex.2 Suddenly, it became crystal clear to his
listening audience that anyone with money could purchase one of these highly
sophisticated medical systems to just “scan around” in his or her living room. Not only
did this revelation rattle the many different medical communities worldwide, but it also
rekindled the ongoing, contentious debate among its health care providers concerning the
appropriate uses for this technology.3.
Unfortunately, the pace at which ultrasound services are spreading throughout the
world, and in particular America, may be exceeding the abilities of the regulatory
agencies to monitor and maintain consumer safety. Notwithstanding any alleged safety
risks ultrasound might pose to consumers, the American public seems increasingly eager
to purchase these services. Although some do see an economic upside for consumers in
1

Sarah Hall, Cruise Keeps Eye on Fetus, http://wwweonline.com/News/Items/PF/0,1527,17834,00.html
(recounting discussion between Barbara Walters and Tom Cruise during an interview where he admitted
that he had purchases an ultrasound system and had technologists showing him how to use it).
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See Sarah Hall, supra note 2.
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Fran Kritz, Doctors Not Fans of Tom Cruise’s Baby Gift,
http://msnbc.msn.cim/id/10309963/print/i/displaymode/1098/ (discussing the various responses issued from
major medical organization that opposed the new acting gig taken by Tom Cruise, as an ultrasound
technologist, after he announced to a national television that he had purchased an ultrasound system so he
and his wife, actress Katie Holmes, could view their developing baby).
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an environment, where ultrasound services are easily purchased, it may be disguising the
potential health risks for those who overutilize them.
Part I of this article will explain why the role of ultrasound in medicine is rising,
and why some entrepreneurs are now seeking to take advantage of the ready availability
of this technology. Although ultrasound technology is capable of conferring many health
benefits to its consumers, entrepreneurs are now recognizing the economic benefits
associated with an expanding market. Unfortunately, some clever entrepreneurs have
seized the moment to promote the nondiagnostic applications for this technology to the
point where they may be exposing consumers to its potential health risks. If this is the
case, then state legislatures, not the FDA, will bear the responsibility for ensuring that
their consumers are shielded from needless exposures. Part II of this article will cover the
existing regulatory options available at both the federal and state levels to check
nondiagnostic uses of this technology. The discussion in Part III will identify the
underlying scientific principles of ultrasound and explain why overexposing consumers
to sound energy may put them at risk. If risks do exist, then more physician involvement,
not less, is needed to ensure prudent use of this technology. In Part IV, the existing
policies related to the prudent use of diagnostic medical ultrasound as promulgated by the
major world organizations will be reviewed. Part V will show the way states, such as
California and Texas, have used legislative initiatives as well as federal and state
regulations to protect their consumers from ultrasound overexposure. This section will
also argue that a total ban on these practices may be counterproductive, and that control
will only be achieved through a collaborative effort between all stake holders, especially
consumers. The final solution, however, will not come without state legislative efforts
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such as those currently unfolding in the California legislature. Such efforts may be
necessary to ensure the safety of consumers and to check the over-utilization of this
technology by some imaging entrepreneurs.
I. A. The Role Diagnostic Medical Ultrasound Plays in Medicine Is Rising.
Diagnostic medical ultrasound has played an increasingly important role in
modern diagnostic medicine. Over the past three decades, diagnosticians have relied on
ultrasound devices to produce sound waves that travel at speeds inaudible to the human
ear to create diagnostic images of the human body.4 Manufacturers of these devices know
their customers, and they know the modern medical community relies heavily on their
technology. They introduce new ultrasound technologies into the medical market place to
feed the needs of their customers.5 Manufacturers are very successful at what they do,
because they commit substantial portions of their engineering resources toward
improving the diagnostic capabilities and clinical applications of these sophisticated
devices.6 One need only look at the financial contributions this technology has made to
the medical market place to understand its importance to modern clinical practice.
In 2000, the total global market for the major cross sectional imaging modalities
was estimated at 8.1 billion U.S. dollars.7 Ultrasound procedures contributed to 2.6
billion U.S. dollars of the total market, and of this total, the U.S. market share accounted
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See Barry B. Goldberg, Internal Arena of Ultrasound Education, 22 JOURNAL ULTRASOUND MEDICINE
549 (2003) (noting a rapid rise of ultrasound occurred beginning in the early 1970s).
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See Fleming Forsberg, Ultrasonic Biomedical Technology; Marketing Versus Clinical Reality, 42
ULTRASONICS 17, 17 (2004), available at http://www.elsevier.com/locate/ultras (citing that new imaging
technologies come to the market to improve diagnostic capability).
6
See Forsberg, supra note 5, at 17.
7
Medical Technology Roadmap—The Current Situation, http://strategis.ic.gc.ca/epic/internet/inmitrcrtim.nsf/print-en/hm01493e.html (comparing the current Canadian medical imaging market to the world
markets, where the total imaging market for the world (composed of ultrasound (2.61 billion), MRI (2.17
billion), and nuclear medicine (3.32 billion)) was estimated at 8.1 billion dollars in 2000, where ultrasound
accounted for 2.6 billion dollars).
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for an estimated 746 million U.S. dollars.8 In 2003, the U.S. ultrasound market rose to
nearly 1.27 billion dollars,9 and now, it is estimated at 1.5 billion dollars, which has led
many experts to predict further growth during the next decade.10 One of the primary
reasons for this rosy economic prediction is the introduction of hand-carried devices
(HCDs) into the market place.11 When these devices were first introduced into the
market, they generated manufacturers nearly 5 million U.S. dollars, which then increased
to an estimated 96 U.S. million dollars in 2003.12 Recently, one analyst predicted that the
ultrasound market will only grow as HCDs make ultrasound technology more available
through cost reductions.13 Although these devices have not been sighted in fetal keepsake
imaging studios or self-referral practices, it is only a matter of time before these devices
do make their presence known, as a more affordable technology. Could it be that HCDs
will follow other technologies, such as pocket calculators, laptop computers, cell phones,
and other technologies, into the hands of consumers?
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See supra note 7 and its accompanying text.
U.S. Ultrasound Markets, http://www.frost.com/prod/servlet/report-brochure.pag?id=A675-01-00-00-00
(identifying potential growth areas in the ultrasound market with three areas as the introduction of handcarried devices or HCUs, the increased utilization in the field of cardiology; and the adoption of ultrasound
technology by new user groups, such as surgeons, anesthesiologists, and emergency medicine physicians,
and these areas will spur further growth in the market from its estimated worth of 1.27 billion dollars in
2003).
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Daniel Lidor, The ‘Baby Face’ Phenomenon, FORBES, May 5, 2006,
http://www.forbes.com/2006/05/09/cruise-ge-ultrasound-cx_dl_0509ultrasound.html (noting that the
research group of Frost and Sullivan claim that Obstetrics-Gynecology ultrasound will account for 225
million dollars of the total ultrasound market, which is now estimated to be 1.5 billion dollars, and they also
expect this market to grow, especially in the area of Ob-Gyn, where by 2010, it will show an annual growth
rate of 8 to 10 percent to yield 270 million dollars).
11
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See U.S. Ultrasound Market, supra note 9.
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imaging systems to users, who previously could not afford high-end cart-based units, and making HCDs
less expensive, but attractive options).
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Perhaps, the best explanation for such lofty predictions for the diagnostic medical
ultrasound market may be related to the physical properties of sound waves used to
acquire ultrasound images.14 Unlike the ionizing radiation emitted from conventional
diagnostic x-ray imaging systems, ultrasound imaging systems produce sound waves,
which are a form of mechanical energy that creates changes in pressure through a series
of molecular collisions.15 The resulting changes in pressure are responsible for
propagating the waves through a tissue medium such as the human body.16 These systems
utilize ultrasound transducers to generate sound waves within frequency ranges that pose
little, if any, risk to those scanned by them.17 Almost everyone believes this is a safe,
unadulterated technology, when it is compared to the other cross sectional imaging
technologies, such as CT, which expose individuals to ionizing radiation. Thus, all
branches of medicine have sought to incorporate ultrasound technology into their
diagnostic armamentariums.18
Ultrasound now accounts for more than one quarter of all diagnostic medical
imaging studies performed throughout the world.19 Although most physicians and the lay
public perceive this technology as risk free, risks do exist, but they are far exceeded by
the diagnostic benefits afforded to those scanned with this technology.20 This point is
underscored by the World Health Organization (WHO), and it recent endorsement of the
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See WAYNE R. HEDRICK, DAVID L. HYKES & DALE E. STARCHMAN, ULTRASOUND PHYSICS and
INSTRUMENTATION 1 (Jeanne Rowland and Lisa Potts eds., Mosby – Year Book 1995) (1985)
(distinguishing diagnostic medical ultrasound from technologies that utilize ionizing radiation to capture
images of the human body that include conventional diagnostic x-rays, nuclear medicine imaging studies,
and computed tomography).
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See HEDRICK, HYKES &. STARCHMAN, supra note 14, at 3.
16
See HEDRICK, HYKES &. STARCHMAN, supra note 14, at 3.
17
See HEDRICK, HYKES &. STARCHMAN, supra note 14, at 249.
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See HEDRICK, HYKES &. STARCHMAN, supra note 14, at 249.
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See Forsberg, supra note 5, at 17.
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See HEDRICK, HYKES & STARCHMAN, supra note 10, at 249.
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distribution and utilization of this technology within third world countries.21 The WHO
promoted increased utilization of these systems, because ultrasound systems were also
cheaper than other cross-sectional imaging technologies, such as CT or magnetic
resonance imaging (MRI) systems.22 The WHO also realized that high quality diagnostic
images required highly skilled ultrasound operators at their controls, if these countries are
going to reap its benefits.23 Because this technology has been, and always will be,
operator dependent, the WHO has encouraged countries to begin ultrasound education
programs to ensure that operators will be well-trained.24 As long as skilled operators are
at the controls of these powerful diagnostic medical devices, its future will remain bright,
but a dark-side to its ready availability in medical market place looms on the horizon.
Yes, indeed, American entrepreneurs have tapped into the lucrative medical
imaging market by taking advantage of the rising number of consumers, who are ready,
willing, and able to access the cornucopia of diagnostic imaging services.25 Now, any
willing consumer can acquire diagnostic imaging studies without ever seeing his or her
primary physician. Consumer initiated studies have become big business, because they
can get them without a note, prescription, or order from a physician.26 Of course, medical
insurers may not cover these medical imaging costs, but who really cares, if consumers
have the dollars to spend on these studies.27
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See Goldberg, supra note 4, at 549.
See Goldberg, supra note 4, at 549-50.
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See Goldberg, supra note 4, at 549-50.
24
See Goldberg, supra note 4, at 550 (noting that the WHO appreciates that operators must be educated in
the proper skills required for operating these powerful systems, and it is encouraging the formation of
ultrasound education programs worldwide).
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See Joshua J. Fenton & Richard A. Deyo, Patient Self-Referal for Radiologic Screening Tests: Clinical
and Ethical Concerns, 16 Journal AM. BD. FAMILY PRACTICE 494, 494 (2003) (noting that Americans for a
price will purchase an ultrasound examination from private facilities).
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Fenton & Deyo, supra note 25, at 494.
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Fenton & Deyo, supra note 25, at 494.
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Some clever entrepreneurs have pushed American medical imaging markets to
different levels of excess by establishing ultrasound photography and ultrasound
entertainment studios.28 Fetal “keepsake” imaging studios allow newly expectant mothers
to view their developing fetuses for entertainment, rather than meeting the medical
necessities of the mother or her baby-to-be.29 Yes, operators of these facilities boast that
they can offer expectant mothers and their family members or friends an opportunity to
see their baby-to-be in a theater-like atmosphere for a price.30 Ample opportunities await
mothers wishing to purchase one of these experiences, because keepsake imaging studios
are springing up throughout the United States from California31 to Washington, D.C.32
Even Texas has its share of centers with catchy titles such as Fetal Photos,33 Womb with
a View,34 First Sight Ultrasound,35 and Clearview Ultrasound.36 Yes, the heartland of
America has morphed itself into a land of imaging opportunity, where the savvy imaging
entrepreneur can cash-in on the needs of willing consumers with medical imaging dollars
to spend.
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Fenton & Deyo, supra note 25, at 494.
Posting of Marc Santora to forums.obgyn.net,
http://forums.obgyn.net/ultrasound/ULTRASOUND.0405/0037.html (May 17, 2004)
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Hawaii; and Los Angeles, CA). (last visited June 29, 2006).
32
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the magic of first seeing your baby” with offices in Virginia and Maryland) (last visited on June 29, 2006).
33
Fetal Fotos, http://fetalfotousa.com/ (listing locations in Arizona, Georgia, Idaho, Minnesota, North
Carolina, Oregon, Texas, and Utah) (last visited on June 29, 2006).
34
Womb with a View, http://www.wombwithaview.com/ (posting office locations in Pennsylvania and
New Jersey) (last visited June 29, 2006).
35
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offices in Illinois, Connecticut, New Jersey, Pennsylvania, and Texas) (last visited on June 29, 2006).
36
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providers in the country) (last visited on Oct. 26, 2005).
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I. B. Imaging Entrepreneurs May Be Using Ultrasound Inappropriately.
Yes, Tom Cruise’s desire to image his baby-to-be with his very own ultrasound
system may seem a tad bizarre or eccentric, but even the medical community cannot
decide whether keepsake imaging qualifies an inappropriate use for this technology.
Although some physicians believe keepsake imaging is inappropriate, others see no
problems whatsoever.37 In fact, there are physicians, operators, and consumers who say
that fetal keepsake imaging is both appropriate and beneficial, especially for the future
parents, as consumers, who may use it to further their bonding experiences.38
Notwithstanding its purported benefits related to bonding, most major medical societies
have aligned themselves with the Food and Drug Administration (FDA) and have
adopted policies that oppose the practice of “keepsake” imaging. They do not believe it to
be one the manufacturers intended for this technology.39
More specifically, the FDA and Code of Federal Regulations classify diagnostic
medical ultrasound systems as medical devices. Because these devices are classified as
medical devices, they also require a licensed physician to issue a note, an order, or a
prescription before anyone is imaged with one of these systems.40 Not only do these
groups consider keepsake imaging of fetuses a potential misuse of a diagnostic medical
device, but also they raise concerns related to the performance of medical imaging studies
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AMA Says Ultrasound In-Utero “Portraits” Are Bad Idea, REUTERS HEALTH, June 21, 2005, available at
http://www.acr.org (citing House of Delegates of the American Medical Association disapproval of the use
of ultrasound for “keepsake” imaging) (last visited on Oct. 29, 2005).
38
See Dulce Zamora, supra note 30.
39
Fetal Keepsake Videos, FDA, Centers for Devices and Radiological Health (Aug. 30, 2005), available at
http://fda.gov/cdrh/consumer/fetalvideos.html (stating that persons who engage in the practice of fetal
keepsake imaging are using ultrasound in a manner unapproved by the FDA) (last visited on Oct. 29,
2005).
40
See Fetal Keepsake Videos, FDA, Centers for Devices and Radiological Health, supra note 39.

8

without a supervising physician who can, formally report results,41 do standard
counseling,42 or perform standard diagnostic examinations.43
All of the aforementioned issues related to the lack physician have been tragically
demonstrated in a recent case report in the medical imaging literature. In that case, a
mother went to one of these keepsake imaging studios for scanning, and left it believing
that her baby-to-be was normal, only to discover during a later diagnostic scan that her
baby-to-be had significant fetal anomalies. Unfortunately for her fetus, it had all the
ultrasonographic features of Trisomy 18 and Smith-Lemli-Opitz Syndrome that went
undetected or unreported by the operator at the fetal “keepsake” imaging studio.44 Not
only did that case raise issues related to failure in detection or reporting of major
anomalies, but also it raised serious medical and ethical issues for both the parents and
their physicians. Perhaps, the most disturbing aspect of this case was the realization that
the parents, who believed their baby-to-be was normal, were given a false sense security
by the operators of the fetal imaging studio who did not report the abnormality,
regardless of their reasons for not doing so.45 Although this case report illustrated all the
potential pitfalls associated with fetal keepsake imaging, it has done nothing to dissuade
the continued performance of these studies by non-physicians.
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ACR Ultrasound Commission Chair Featured in Baltimore Sun Article on Fetal Keepsake Videos,
available at http://www.acr.org/s_acr/doc.asp?TrackID=&SID=1&DID=21103&CID=2580&VID=2
(citing Carol M. Rumakc, M.D., as chair of the ACR Commission on Ultrasound, statement on the position
of the ACR that ultrasound is performed for medical purposes) (last visited on Oct. 29, 2005).
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AMA Says Ultrasound In-Utero “Portraits” Are Bad Idea, supra note 35.
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Naomi Greene & Lawrence D. Platt, Nonmedical Use of Ultrasound: Greater Harm than Good, 24
JOURNAL ULTRASOUND MEDICINE 123, 124-25 (2005).
44
See Greene & Platt, supra note 43, at 123.
45
See Greene & Platt, supra note 43, at 124-25 (expressing concern for the mother or family member who
sees their baby-to-be, as normal but no one, including the ultrasound operator or technologist, recognizes or
informs the mother that an obvious problem is present during the scanning session).
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In fact, some studio operators continue to perform these studies without ever
asking for or receiving a formal order from a physician, or even getting a physician to
review their work.46 Moreover, it has done nothing to alter the opinion of some
physicians and studio operators who believe that “keepsake” imaging provides a
pleasurable experience to those willing to pay for them.47 In fact, any future
psychological harms related to the mislabeling of abnormal “baby pictures” as normal,
when they clearly are not, may never be fully known.48 More likely than not, the actual
number of missed cases will never be known, because many operators do not see
themselves as performing diagnostic services and thus, they do not report their findings.49
In fact, some operators, who perform these studies without physician supervision,
have said they will ignore fetal abnormalities, even if a “fetus has three legs.”50 The
“why” underlying such ridiculous pronouncements remains unclear; but perhaps,
operators choose this stance in order to avoid any legal sanctions that might be levied
against them for the unauthorized practice of medicine, if they make a medical
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See Greene & Platt, supra note 43, at 124.
See Peter M. Doubilet, Letter to Editor, Entertainment Ultrasound, 24 JOURNAL ULTRASOUND MEDICINE
251, 251 (2005) (stating the belief that “resourceful entrepreneurs have found willing client for nonmedical
use of ultrasound: providing a pleasurable experience and keepsake images or videos for expectant mothers
and parents.”
48
See Frank A. Chervenak & Laurence B. McCullough, An Ethical Critique of Boutique Fetal Imaging: A
Case for the Medicalization of Fetal Imaging, 192 AM. JOURNAL OF OBSTETRICS AND GYNOCOLOGY 31,31
(2005).
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Emily Huhn, Photo Studio In-Utero, http://www.bu.edu/sjmag/pfstories/pffetalphotos.htm (recognizing
Ms. Twiss of Sneak Peek’s acknowledgement that Ms. Twiss operates in gray area and would welcome
regulation, but she also does not claim to run a medical practice or offer medical procedures, and she also
requires her patients to be under care to avoid concerns about diagnosis of fetal abnormalities nor does she
do anyone’s first ultrasound).
50
Press Release, AIUM Opposes Uses of Ultraound for Entertainment (Nov. 5, 2005) (on file with author)
(noting that one operator from an article in the Wall Street Journal was quoted as saying ‘I don’t care if the
fetus has three legs, I’d only point out two. I don’t care if the uterus has fibroids, or if they have too much
or too little amniotic fluid or where the placenta is. I have informed these people I’m not a doctor, that I’m
not trying to find abnormalities’).
47
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diagnosis.51 Has the almighty dollar become so important that trained professionals will
forsake their professional responsibilities along with their common sense just to make a
buck and avoid legal sanctions? Although such attitudes, more likely than not, reflect
those of a fringe element rather than the majority of honorable diagnostic medical
sonographers, such pronouncements only bolster the need for more physician oversight,
not less.
Not only is the number of fetal keepsake imaging studies increasing, but also the
number of screening studies obtained sans physician referral is growing.52 Now,
consumers may select from a variety of high-tech imaging technologies including
diagnostic medical ultrasound, to satisfy their perceived imaging needs.53 Ultrasound
imaging studies, such as heel ultrasounds for osteoporosis and carotid ultrasounds for
atherosclerotic disease, are coming to rural medical imaging market places via mobile
ultrasound services.54 These van-based ultrasound services now serve consumers in fortythree states.55 The lure for these studies for many consumers is their belief that they will
receive a peace-of-mind after the completing of one of these screening studies.56 This
state of nirvana for its recipients may only be a temporary one, once they realize that their
51

Louisiana State Board of Medical Examiners, Statement of Position, Self-Referred Diagnostic
Ultrasound Screening, http://www.lsbme.org/documents/positionstatement/Ultrasound Screening.pdf
(explaining that the Louisiana State Board of Medical Examiner believes, after reviewing the scope of the
Louisiana Medical Practice Act and practices of ultrasound screening within the State, that “undertaking to
perform and/or providing the results of ultrasound screening constitutes the practice of medicine. Strict
application of this conclusion, would, thus, constrain the Board in the discharge of its responsibility to
safeguard the public health, welfare, and safety against the ‘unauthorized and unqualified practice of
medicine,’ to take appropriate enforcement action against persons and firms who, through personnel other
than licensed physicians, provide ultrasound screening to the public.”).
52
See Fenton & Deyo, supra note 25, at 496-99.
53
See Thomas H. Lee & Troyen A. Brennan, Direct-to-Consumer Marketing of High-Technology
Screening Tests346 NEW ENG. J. MED. 529, 529 (2002) (increasing number of entrepreneurs, including
physicians, are offering screening tests to the general public, which are not covered by insurance for fees
that generally range from 300 to 1000 dollars).
54
See Fenton & Deyo, supra note 25, at 496.
55
See Fenton & Deyo, supra note 25, at 494.
56
See Lee & Brennan, supra note 53, at 529.
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“lack of a physician referral” means that they may not have access to a physician who is
able to receive their report.57 Even if one of these consumers has a physician who will
take their report, there is no guarantee that the physician will know how to interpret the
abnormal results contained within the report.58 Moreover, many of these self-referred
imaging tests, including those acquired with diagnostic medical ultrasound, have yet to
prove themselves, as effective screening tools within the general population.59
Nevertheless, the position that diagnostic medical ultrasound occupies within the medical
imaging market place is likely to continue expanding over the next decade as the newer,
smaller, less expensive portable ultrasound systems meet FDA approval and enter into
service.60 Yes, the ultrasound business continues to be big business for its manufacturers,
physicians, and consumers, and the business will just keep on growing with every new
piece of ultrasound equipment that rolls off the assembly-line into the medical imaging
market.
Many states are only beginning to appreciate the inherent problems associated
with fetal keepsake studies, and ultrasound screening studies obtained through the
process of consumer self-referral.. States have taken a variety of approaches to deal with
the health and safety concerns related to self-referral by consumers. Some states, such as
Texas, have taken action against fetal keepsake imaging studios by enforcing both state
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See Fenton & Deyo, supra note 25, at 496.
See Fenton & Deyo, supra note 25, at 494.
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See Fenton & Deyo, supra note 25, at 497-99.
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Danit Lidor, The ‘Baby Face’ Phenomenon, supra note 10 (noting predictions from Frost and Sullivan
that Obstetrics-Gynocology ultrasound will account for 225 million dollars of the total ultrasound market,
where the total market for ultrasound is estimated at 1.5 billion dollars for 2006 and both the total market
and market for Obstetrics-Gynocology devices should grow until 2010 when it begins to taper off to a five
to six percent annual growth in which portable devices will show a sustained growth at twenty percent
during the same period).
58
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and federal drug laws,61 Other states, such as Arizona, have been unable to bring any
actions, notwithstanding calls for action from its medical community, because they lack
state laws to regulate these imaging facilities.62 Still other states, such as New York, have
only recently introduced legislation that would restrict the use of diagnostic medical
ultrasound on pregnant women unless such studies were either ordered or referred by a
licensed physician, nurse practitioner, or licensed midwife.63 Louisiana, on the other
hand, has attempted to curb non-physician-based ultrasound screening studies by placing
under Louisiana law by defining them as an unauthorized practice of medicine.64
Unfortunately, regulatory agencies within most states have found these practices very
difficult to control. Even the FDA has demonstrated its impotence in regulating practices,
such as keepsake imaging, where it has yet to close a studio.65
California, however, has taken a proactive approach to the problem by becoming
the first state to address consumer safety related to keepsake imaging by drafting and
adopting legislation to regulate this practice. In 2005, the California legislature passed a
law requiring keepsake imaging providers to inform their consumers that the FDA does
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See Press Release, Texas Att’y Gen. Greg Abbott, Attorney General Abbott Obtains Agreements with
Four Keepsake Ultrasound Imaging Companies (Apr. 7, 2003) available at
http://www.oag.state.tx.us/oagnews/release.php?id=885 (announcing that four ultrasound companies in
Texas had agreed to initiate physician oversight as required by law. Moreover, the businesses were offering
ultrasounds in a “storefront setting,” and they must use ultrasound only with physician oversight since these
machines are not “toys.”) (last visited on Oct. 25, 2005).
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Parents-to-be Opt for Previews, Ariz Sun, Jan. 8, 2005, available at
http://www.acr.org/s_acr/sec_healthnews.asp?TrackID=&SID=1&DID=19975&CID=31 (stating that
Arizona does not regulate the use of ultrasound for keepsake imaging) (last visited on Oct. 29, 2005).
63
Posting of Art Fougner to forums.obgyn.net,
http://forums.obgyn.net/ultrasound/ULTRASOUND.0405/0037.html (May 16, 2004) (posting states that
New York Senate Deputy Majority Leader Dean G. Skelos introduced, on May 6, 2004, legislation
prohibiting the non-medical use of ultrasound solely for entertainment purposes) (last visited on Oct. 29,
2005).
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See supra text and accompanying note 61.
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Emily Huhn, Photo Studio In-Utero, http://www.bu.edu/sjmag/pfstories/pffetalphotos.htm (noting that
technically the FDA regulates these devices and has issued warning letters, but has yet to close any of the
businesses down) (last visited on May 27, 2006).
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not approve of the use of diagnostic medical ultrasound for fetal keepsake imaging.66
After Tom Cruise recently announced his purchase of one of these sophisticated systems
for home use in the fall of 2006, the California Assembly went back into action over the
issue of fetal keepsake imaging.67 On May 4, 2006, it passed AB 2360, which may be the
first legislative effort by a state that specifically aims to regulate access and distribution
of diagnostic medical ultrasound systems from manufacturers to consumers.68 This Bill
prohibits manufacturers or other persons from “selling, leasing, or otherwise distributing”
ultrasound systems within the state to a specified group of persons or facilities.69
Legislative efforts may not stop here since recent events have spurred renewed requests
from the medical professionals for more regulatory controls on the nonmedical uses of
ultrasound imaging devices.70
After all, modern medicine is becoming more consumer-driven with each passing
day. Consumers, who are able to afford these services, apparently, want them, and they
will seek them out wherever and however they can. Safety, not consumer-driven selfgratification or monetary gain, should be the primary driver in the regulatory debate.
66

See CAL. HEALTH & SAFETY CODE § 123620 (Deering 2006) (“A person or facility that offers fetal
ultrasound, or similar procedure, for keepsake or entertainment purposes shall disclose to client prior to
performing the procedure, in writing, the following statement: ‘The federal Food and Drug Administration
has determined that the use of medical ultrasound equipment for other than medical purposes, or without a
physician’s prescription, is an unapproved use.’”).
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Beyond Tom Cruise-The Bigger Ultrasound Picture, http://medicalnews
today.com/printerfriendlynews.php?newsid=34749.
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AB 2360 Assembly Bill-Vote Information, http://www.leginfo.ca.gov/pub/bill/asm/ab_23512400/ab_vote_20060504_1135_asm_floor.html (reporting results of a vote cast on May 4, 2006 with sixtysix members recording yeas and ten members registering noes).
69
A.B. 2360, 2005-06 Leg., Reg. Sess. (Cal. 2006) (as passed by Assembly, May 4, 2006) (prohibiting a
manufacturer or other person in California from selling, leasing, or otherwise distributing diagnostic
ultrasound imaging systems to any person other than a licensed practitioner who is authorized to use said
system within the scope of their practice, licensed medical facility, a person or entity that provides
diagnostic ultrasound services to said persons or entities, and who is also under their general supervision as
well as other specified persons and entities).
70
Tom Cruies’s Reported Unsupervised use of Fetal Keepsake Ultrasound Raises Risk for Baby and Is
Potentially Unlawful, http://www.acr.org/s_acr/doc.asp?CID+2540&DID=22897 (last visited on Jan. 29,
2006).
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Moreover, the debate should not be couched in terms of a turf war, where jealous
physicians are attempting to protect their practices. On the contrary, the primary goal of
regulatory enforcement should be consumer safety and protection, as a way to maintain
the availability of ultrasound services without overly restricting its use.
II. The Unintended Uses of Diagnostic Medical Ultrasound Is a Regulatory Issue.
In August 1994, the FDA became aware of these nonmedical uses of diagnostic
medical ultrasound,71 and it requested assistance from members of the ultrasound
industry as well as the medical community with discouraging consumers from seeking
these services.72 The primary concern for the FDA was patient safety since reports were
surfacing that some pregnant consumers were scanned for up to one hour.73 Even so,
some physicians still question the position adopted by the FDA regarding fetal keepsake
imaging,74 because no documented acute injuries related to diagnostic medical ultrasound
have been reported in over three decades of use.75 Since 1994, the FDA has encouraged
states, such as Texas, to apply their existing drug laws to curb the nonmedical use of
diagnostic medical sonography.
II. A. States May Use Federal Law to Regulate the Unintended Use of
Ultrasound.
States may apply the existing federal regulations covering diagnostic medical
ultrasound systems, where Title 21 of the Code of Federal Regulations classifies these
systems as Class II devices, whether these devices are intended for obstetrical76 or non-
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See Fetal Keepsake Videos, FDA, Centers for Devices and Radiological Health, supra note 39.
See Fetal Keepsake Videos, FDA, Centers for Devices and Radiological Health, supra note 39.
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See Fetal Keepsake Videos, FDA, Centers for Devices and Radiological Health, supra note 39.
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See Dulce Zamora, Prenatal Portraits: Darling or Dangerous?, supra note 30.
75
See HEDRICK, HYKES & STARCHMAN, supra note 14, at 249.
76
See Food and Drugs, 21 C.F.R, § 884.2225 (2005) (identifying an ultrasonic imager in obstetrics and
gynecology in part (a) as a device designed to transmit and receive ultrasound energies from a female
patient by “pulsed echoscopy,” which can provide visual images of “some physiological or artificial
72
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obstetrical77 use. The existing regulations further define ultrasound systems utilized in
non-obstetrical imaging, as either “ultrasonic pulsed [D]oppler imaging systems”78 or
“ultrasonic pulsed echo imaging systems.” 79 Title 21 also covers ultrasound equipment,
such as the diagnostic ultrasonic transducer, which defined as a device that utilizes a
piezoelectric material to generate sound waves from electrical impulses.80 These
regulations address the major accessories required in acoustical image acquisition, such
as acoustical gel, by also classifying them as devices.81 Because all of these items qualify
as devices, they come under the definition of a “prescription device,” which means a
physician must give an oral or written order for an ultrasound study.82
Moreover, the regulations require an operator of “device-user-facility” to make
reports related to any deaths or serious injuries that may have occurred during the
operation of one of these devices to the FDA.83 A device-user-facility may be a “hospital,
ambulatory surgical facility, nursing home, outpatient diagnostic facility, or outpatient
treatment facility … that is not a physician’s office.”84 An operator of a device- user-

structure, or fetus, for diagnostic purposes during a limited period of time. …(b) Classification. Class II
(performance standards).”).
77
See Food and Drugs, 21 C.F.R. § 892.1560 (2005) (identifying “an ultrasonic pulsed echo imaging
system as a device intended to project a pulsed sound beam into body tissue to determine the depth or
location of tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the
tissue interface and back to the receiver. This generic type of device may include signal analysis and
display equipment, patient and equipment’s supports, component parts, and accessories. (b) Classification.
Class II.”).
78
See id.
79
See Food and Drugs, 21 C.F.R. § 892.1550 (2005) (stating that “an ultrasonic pulsed [D]oppler imaging
system is a device that combines the features of continuous wave [D]oppler-effect technology with pulsedecho effect technology ….”).
80
See Food and Drugs, 21 C.F.R. § 892.1570 (2005).
81
See Id.
82
See Food and Drugs, 21 C.F.R. § 801.109 (2005) (defining, in part, a prescription device as one which
potentially has harmful effects, and directing the use of such device by a practitioner licensed under state
law)
83
See Food and Drugs, 21 C.F.R. § 803.1 (2005) (requiring user facilities to report deaths and serious
injuries caused or contributed to by a medical device).
84
See Food and Druugs, 21 C.F.R. § 803.3 (2005) (providing the definitions for device user, and the
reporting requirements for a device user facility and and includes “… Device user facility means a hospital,
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facility must also make Medical Device Reports (MDR) annually,85 create written MDR
reporting procedures,86 and keep written MDR reports on file for inspection by the
FDA.87 These Regulations recognize the concern for potential harm, and the FDA has
also stated that operators who misuse ultrasound (“a prescription device”) by performing
imaging services “without a physician’s order may be violating state or local laws or
regulations regarding the use of a prescription medical device.”88
Unfortunately, states have had mixed results when they have tried to bring
enforcement actions against those who perform fetal keepsake imaging studies, because
ultrasound devices are Class II, not Class III devices.89 Although a Class II device is
subject to special controls,90 it is not subject to the more stringent requirements placed on
those put into Class III.91 Even though operators may be performing nondiagnostic

ambulatory surgical facility, nursing home, outpatient diagnostic facility, … Outpatient diagnostic facility.
(1) Outpatient diagnostic facility means a distinct entity that: (i) Operates for the primary purpose of
conducting medical diagnostic tests on patients, (ii) Does not assume ongoing responsibility for patient
care, and (iii) Provides its services fro use by other medical personnel.”).
85
See Food and Drugs, 21 C.F.R. § 803.10 (2005) (stating essentially that a device user facility must
submit reports of adverse events).
86
See Food and Drugs, 21 C.F.R. § 803.17 (2005) (establishing that a user facility, importer or
manufacturer must put into place written MDR report procedures).
87
See Food and Drugs, 21 C.F.R. § 803.18 (2005) (establishing that a user facility must create ‘MDR event
files’ in written or electronic form, and the information related to adverse events must be in the possession
of the user facility).
88
Fetal Keepsake Videos FDA, Centers for Devices and Radiological Health, supra at note 39.
89
See Rayford v. State, 16 S.W.3d 203, 207-8 (Tex. App.—Dallas 2000, pet. denied) (explaining that
ultrasound devices are Class II, not Class III, devices and that the operator of such devices as an obstetrical
ultrasound system may acquire fetal keepsake images, where the operator may misbrand the device, but it
does not adulterate the device, because this nondiagnostic use, such as fetal keepsake imaging, was not so
substantial an alteration in use that it became a “new intended use,” which is ultimately determined by the
party responsible for labeling i.e. the manufacturer, and not the party who owns or operates the system
under 21 U.S.C.A. § 360c(I)(E)(I)).
90
See Federal Food, Drug, and Cosmetic Act, 21 U.S.C.A. § 360c(a)(1)(B) (West 1999) (providing that a
device must be placed into Class II if general controls by themselves are insufficient to reasonably assure
safety and effectiveness of the device, where specific information is available that indicate special controls
are need to provide “such assurance, including the promulgation of performance standards, postmarket
surveillance, patient registries, development and dissemination of guidelines …”).
91
See Food and Drugs, 21 U.S.C.A. § 360c(a)(1)(C) (West 1999) (providing that a device cannot be placed
into Class II, if there is insufficient information is available to determine whether special controls would
provide reasonable assurance of its safety and effectiveness, it supports or sustains human life or its use is
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studies when they provide keepsake imaging services, this does not mean that the
operators have also substantially altered the use of this technology to qualify it as a “new
intended use.”92 In fact, operators may violate some sections of federal regulations, but
not other sections, which means successful state enforcement actions requires linkage of
specific acts to specific code or regulatory violations before a given state may effectively
prosecute a case.93
II. B. States May Regulate Through Their Existing Drug Laws, if They Have
Them.
Although not all states have enacted legislation to help control the misuse of this
technology, Texas is one of several states that has enacted drug laws to regulate the use
of medical devices within its borders. Texas law classifies diagnostic medical ultrasound
systems as a “device.”94 Not only does it classify this technology as a “device” but it also
considers this type of “device” a “dangerous drug.”95 A “person” violates the Dangerous
Drug Act when he or she “… possesses a dangerous drug unless the person obtains the
drug from … a practitioner acting in the manner described by sect. 483.042(a)(2).” 96
Moreover, the Act states that “a person commits an offense if the person delivers or
offers to deliver a dangerous drug … (2) unless (A) the dangerous drug is delivered or
offered for delivery by: (i) a practitioner in the course of practice, or (ii) a registered

substantially important to preventing human impairment, and it presents a potentially unreasonable risk of
illness or injury).
92
See id at 208.
93
See id at 208.
94
See Texas Food, Drug, and Cosmetic Act, TEXAS HEALTH & SAFETY CODE ANN. § 431.002(13) (Vernon
Supp. 2005) (defining ‘Device’ as an “instrument, apparatus, implement, machine, contrivance … .”).
95
See Texas Food, Drug, and Cosmetic Act, TEXAS HEALTH & SAFETY CODE ANN. § 431.001(2) (Vernon
Supp. 2005) (defining a ‘Dangerous Drug’ as a “device … .”).
96
See Texas Dangerous Drug Act, TEXAS HEALTH & SAFETY CODE ANN. § 483.041(a) (Vernon Supp.
2005).
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nurse or physician assistant under sect. 157 of the Tex. Occ. Code.”97 A person may also
violate the Texas Food, Drug, and Cosmetic Act where that person uses diagnostic
medical ultrasound in a manner that the FDA did not intend, and thus “adulterates the
device.”98 The Code also provides that if the device is falsely or inappropriately labeled
or falsely advertised, then person has committed a violation.99 Clearly, Texas perceives
the potential for misuse that could harm that diagnostic medical ultrasound as a “device”
may be a potential risk to the public, and it may regulate such a device. Unfortunately,
not all physicians or members of the public appreciate the inherent risks associated with
this technology because they assume there is little or no risk,100 and the courts may not
agree on which practices or acts violate a given regulatory section.101
III. The Potential Bioeffects from Ultrasound May Explain Why Regulation Is
Needed.
Why should federal and state authorities enforce their current laws, or enact new
ones directed toward drug enforcement, if diagnostic medical ultrasound poses little if
any, risks to those scanned with it? To answer this question, one must understand the
basic physical principles underlying the generation of ultrasound waves, and their
relationship to the theoretical risks related to ultrasound waves. The physical principles
key to any discussion of the risks associated with diagnostic medical ultrasound are
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See Texas Dangerous Drug Act, TEXAS HEALTH & SAFETY CODE ANN. § 483.042 (Vernon 2003).
See Texas Food, Drug, and Cosmetic Act, TEXAS HEALTH & SAFETY CODE ANN. § 431.111 (Vernon
2003).
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See Texas Food, Drug, and Cosmetic Act, TEXAS HEALTH & SAFETY CODE ANN. § 431.112 (Vernon
Supp. 2005) (stating that “A drug of device shall be demed to misbranded (o) in the case of any restricted
device distributed or offered for sale in this state, if: (1) its advertising is false or misleading in any
particular;”).
100
Dulce Zamora, Prenatal Portraits: Darling or Dangerous?, supra at note 30.
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Rayford, 16 S.W.3d at 208-11 (explaining why the practice of fetal keepsake imaging by nonphysicians
may violate certain sections of the Code of Federal Regulations, but not other sections, where keepsake
imaging may qualify as an unintended use, but not a new intended use of ultrasound imaging systems
during imaging of the fetus).
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related to the generation of sound waves, the intensity or power of sound waves, and the
mechanical properties of sound waves.102 Audible sound, as a mechanical energy, is
produced by periodic changes in the pressure within a medium, such as air or water,
where molecules of the medium are caused to oscillate in a repetitive fashion or cycle.103
These oscillating molecules interact with each other to create periodic changes in
pressure, which then propagate the wave through a distance within the medium, such as
tissue.104 In order for sound to propagate through a medium, it must interact with a
medium, which is elastically deformable.105 Thus, sound, as a mechanical energy,
propagates through tissue within an energy spectrum, which is also outside the energy
spectrum for ionizing radiation or electromagnetic radiation, and therefore, it lacks the
risks associated with conventional x-rays.106 Nevertheless, several physical parameters of

the ultrasound may cause biological effects worthy of regulation.107
III. A. Ultrasound Beam Intensity and Output Levels Impact Patient Safety.
One of the key considerations in the production of biological effects by ultrasound
is its intensity or the “rate of energy flow through a unit area.”108 Unfortunately, modern
systems utilize pulsating scanning technologies that produce complex ultrasound fields
that vary over time, which makes any determination of the absolute intensity of their
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 1-8.
See HEDRICK, HYKES & STARCHMAN, supra note 14, at 1 (explaining that sound audible to the human
ear oscillates in the range of 20 kHz).
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 3.
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 3.
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 250.
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Stanley B. Barnett et al., International Recommendation and Guidelines for the Safe Use of Diagnostic
Ultrasound in Medicine, 26 ULTRASOUND MEDICINE & BIOLOGY 355, 356 (2000) (citing rising output
levels on modern systems may substantial increase the intensity and thus exposure levels tissues receive,
especially in cases where the human embryo is scanned).
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 250.
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beams difficult.109 Moreover, the intensity of these modern pulsating transducers exhibits
a temporal and spatial dependence, where temporal variations that occur within any given
pulse further complicate determinations of an absolute intensity for the beam.110 Thus, the
inherent characteristics of the beam produced by most modern ultrasound system explain
why the FDA and other organizations continue to oppose the non-medical applications of
diagnostic medical ultrasound.111
III. B. Safety Remains the Issue for Modern Ultrasound Technologies.
Patient safety remains an issue for the FDA because many of the early
epidemiological studies related to the biological effects of ultrasound beam on humans
were methodologically flawed.112 Some of these early studies were also performed with
ultrasound systems that operate at much lower powers or output intensities than the
systems in most user facilities today.113 Moreover, many of these early studies were
animal studies, where test subjects received ultrasound exposures at higher levels and
longer durations than those achieved with the current clinical systems.114 Any
extrapolations from past animal studies to current human experience may be tenuous at
best.115 The bottom line is the absolute risks posed by diagnostic medical may not be
known until more studies are done at the higher energy levels employed by modern
ultrasound systems.116
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 254 (noting that any given ultrasound field may
be defined by a limited set of parameters, such as intensity or power of the beam, which indicates the
potential for tissue damage).
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 250-53.
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 254.
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See Barnett, supra note 107, at 357.
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 260.
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115
See Barnett, supra note 107, at 356.
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Not only do the system factors, such as the output levels and transmission
frequencies of the modern ultrasound system impact patient safety, but also non-system
factors, such as those associated with the operator of these systems, influence safety.117
Operators are now given the ability to control the power output or intensity and
transmission frequencies selected during an ultrasound exam, which in turn, modulate the
potential biological effects that could result from an exam.118 Modern ultrasound system
operators determine the amount of energy a given volume of tissue receives during a
study by the controlling the amount of time they spend scanning.119 Scan-times for any
one operator may vary depending on the skill of the individual operator or the degree of
complexity or difficulty in obtaining diagnostic information to complete a study.120 So,
the longer the scan-time or dwell time on a particular volume of tissue, the more likely
the volume of tissue scanned may experience biological effects.121 Even the thickness of
the tissue scanned by an operator may impact ultrasound exposure levels, where the more
superficial tissues may receive a higher dose of ultrasound energy.122 Thus, well-trained
operators should spend only the necessary amount of time scanning needed to acquire the
appropriate diagnostic information.123
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See HEDRICK, HYKES & STARCHMAN, supra note 14, at 254.
See Barnett, supra note 107, at 359 (noting that longer pulses and higher pulse repetition frequency rates
may increase the potential for biological effects, such as those caused by heating, which could potentially
cause tissue damage, which theoretically could impact patient safety).
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See Barnett, supra note 107, at 359
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See Barnett, supra note 107, at 359
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III. C. Risk Related to US May Increase as Manufacturers Raise Their Beam
Intensities.
Each ultrasound system or device has a range of power outputs or intensities that
it can achieve to improve the resolution of a particular system.124 In 1993, the FDA
allowed ultrasound manufacturers to raise the intensity levels of their systems by setting
the overall maximal limit for an ISPTA of all equipment at 720 mW/cm2.125 The intensity,
as measured as ISPTA, for any given ultrasound system varies, depending upon the type of
ultrasound study performed with a given ultrasound system.126 The FDA has allowed
manufacturers to achieve these higher intensity levels as long as their systems can display
output information related to the ultrasound intensity.127 Unfortunately, a 1997 evaluation
of equipment conducted in the United Kingdom suggested that the intensity levels
achievable with modern diagnostic systems may be greater than the expected maximum
intensities.128 Thus, it may now be possible for a medical ultrasound system to expose the
fetus or embryo to eight times the intensity previously allowed.129
The FDA currently allows ultrasound equipment manufacturers to achieve higher
intensities up to the 720 mW/cm2 maximum, if their system can display on their output
of time adhering to the principle that exposure of the patient to ultrasound should be as “Low As
Reasonably Achievable”).
124
See Barnett, supra note 107, at 357.
125
See Fowlkes, supra note 123 (providing FDA Track 3 limits for ultrasound systems as defined for 510k
as ISPTA.3 (720 mW/cm2) and ISPPA.3 (190 mW/cm2)
126
See HEDRICK, HYKES & STARCHMAN, supra note 14, at 250-54 (explaining that the current intensity
levels, as measured by I(SPTA), for any given ultrasound system vary for phased array and mechanical
scanners ( 2 to 200 mW/cm2), pulsed Doppler for obstetric studies (0.6 to 75 mW/cm2), and pulsed Doppler
for peripheral vacular studies (350 to 700 mW/cm2))
127
See Fowlkes, supra note 123 (noting that the FDA relaxed its pre-amendment levels as long as the
manufacturers use the Output Display Standard (ODS), where the system operator is able to monitor both
the thermal and mechanical effects of the ultrasound beam by monitoring two display indices—the
mechanical and thermal indices).
128
See Barnett, supra note 107, at 359 (citing data from J Henderson et al., A Review of the Acoustic Output
of Modern Diagnostic Ultrasound Equipment, 10 BMUS BULLITEN 10 (1997) in Table 2 (supplying data that
show a greater than expected maximum intensities (I(SPTA) for a conventional B-mode scan (1000
mW/cm2), pulsed Doppler scan (9000 mW/cm2), and Color flow scans (2000 mW/cm2).
129
See Barnett, supra note 107, at 356.
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display screen the two key potential predictors of biological effects: mechanical index
and thermal index.130 The two indices reflect the three potential interactions the
ultrasound beam may have with human tissue that cause damage: mechanical (direct or
indirect tissue damage), thermal (tissue heating), and cavitation (inertial and noninertial
forms).131 These events may also lead to secondary events, such as microstreaming and
altered chemical reaction rates, which can produce tissue injury.132 Thus, modern system
manufacturers may obtain FDA approval for their systems, if they can display the
mechanical and thermal indices for the operator to manipulate, and they adopt the Output
Display Standard (ODS).133
III. D. The ODS May or May Not Reduce the Risk for Injury.
The ODS was established to help reduce the potential for biological effects related
to thermal and mechanical damage by setting a reasonable upper limit on index values.134
Unfortunately, there are no absolute index values, only approximations of these values
are available.135 The current recommendation to the ultrasound operator is to keep these
values as low as possible with an MI less than 1.9, to satisfy regulatory requirements.136
If display indexes rise above one, then the operator should take appropriate
countermeasures to lower the index to lower it, keeping the exposure “as low as
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reasonably allowed (ALARA).”137 Appropriate countermeasures may include: reducing
the pulse repetition frequency, reducing the dwell time, or any other parameter that will
reduce exposure, but maintain image quality.138
In order for these countermeasures to be effective, the ultrasound operator needs
to understand the ODS, and appreciate its significance. Unfortunately, many of the
current ultrasound display systems do not present the information in a manner that is
easily accessed or understood by the operator.139 One of the potential problems with the
ODS and relaxation of FDA requirements is some operators may not understand the
ODS.140 This potential pitfall was illustrated at a 2002 meeting of the British Medical
Ultrasound Society, where a survey of manufacturers and their technical support staff
revealed that many of them were unaware of the ODS.141 In fact, some operators were
observed scanning healthy models at thermal indices that exceeded one.142 Others were
caught unaware of the British guidelines mandating that exposure levels be kept to a
minimum when scanning models.143 These observations are worrisome, since they
suggests that other, less knowledgeable or experienced operators in general practice, may
not be aware of the ODS.144
If this possibility is confirmed, then the ODS may not be effective, because
operators do not understand it. If it is not effective, then federal and state authorities may
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have an even greater need to regulate the nonmedical uses of this technology, since
patients may be experiencing unnecessary exposures to higher acoustical energy levels
during fetal keepsake imaging. Even so, many continue to believe that the FDA
classification of ultrasound as “prescription device” and disapproval of nonmedically
related ultrasounds is misplaced, because no acute harmful effects have been definitely
shown in humans in over three decades of scanning.145
III. E. The Biological Effects Related to Ultrasound Have Not Been Completely
Elucidated.
Unfortunately, much information on biological effects of ultrasound on humans is
undiscovered. There are many variables that may determine if, and when, the ultrasound
beam is going to cause a biological effect.146 Biological effects will depend on the wave
mechanics as well as the tissue system coming into contact with the beam.147 Multiple
variables may play a role in determining whether ultrasound could potentially cause
tissue damage. Some of these variables may include the acoustical properties of the beam
as well as the characteristics of the tissue scanned, which may also include the biological
properties, metabolic or physiologic functions and location.148 These factors may also
limit any manifestation of tissue injury, where tissue targets are small, unless the tissue
involves some critical pathway such as the nervous system or rapidly dividing cells, like
those in the developing embryo.149
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If ultrasound is going to cause a tissue injury, it will do so through mechanical,
thermal, or cavitation effects on the surrounding tissues.150 Any mechanical effects that
might occur, generally, do so near solid boundaries.151 The potential for thermal effects
related to beam heating of tissues, on the other hand, raises the most concern for
production of biological effects.152 Temperature alterations in tissue may be affected by
the intensity of the ultrasound beam as well as the properties of the tissues along with
their physiologic surroundings.153 Body fluids, such as urine, amniotic fluid, or cerebral
spinal fluid, experience negligible elevations in temperature, because their protein content
is low and thus, they absorb very little, if any, of the acoustical energy of the beam.154
Skin, tendons, spinal cord, and bone (highest), all have increased protein content, which
puts them at risk for heating.155 If tissue heating occurs, then it must be extremely rapid
and reach the critical 5° Celsius temperature rise before it causes tissue damage.156 Any
heat related injuries occurring in humans would likely be seen in the developing fetus.157
Fortunately, any ultrasound-induced damage related to heat remains only a
theoretical risk, but the mere existence of this possibility should suggest that
sonographers exercise caution when they scan these individuals at a thermal index greater
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than one. Not only can the ultrasound beam heat tissues and cause tissue damage, but the
beam itself may also generate pressure amplitudes of sufficient pressure to form gas
bubbles,158 especially in gas containing organs, such as bowel.159 These inertial cavitation
effects have the potential to break chemical bonds and form biological free radicals.160
Although these free radicals may bind with DNA and cause chromosomal damage, this
event has not been demonstrated thus far.161 If inertial cavitation effects are detected, they
have occurred at gas-tissue interfaces, such as mammalian lung, at energy levels within
the diagnostic range.162 In the one study that detected cavitation effects, they were
associated with pulmonary capillary bleeding or extravasation.163 This observation raised
concern for affects in humans, especially in clinical situations where gas may be present,
such as gas-forming infections or infusions.164
Based on the foregoing discussion, the potential for biological effects on humans
is real, but unfortunately, very little, if any, epidemiological data is available to support
the existence of such effects.165 Some early studies demonstrated neurologic effects in
children, such as an abnormal grasp or tonic neck reflex or dyslexia, but these findings
may have been due to multiple hypotheses testing or chance.166 One study has observed a
higher incidence of delayed speech in children exposed to ultrasound in utero than in
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those not scanned with ultrasound.167 The actual statistical significance of this
observation is questionable, since the number of children studies was small and bias
could have been a factor.168 Reductions in birthweight have also been reported in the
literature, but this study may have been designed to test an unrelated hypothesis.169
Because of the potential for sister chromatid damage, studies have looked at childhood
cancer, but no studies to date have demonstrated an association between in utero
ultrasound exposure and cancer.170 Concern for the potential of non-right handedness in
children exposed to ultrasound in utero has been assessed, but no definite relationship has
been confirmed.171 A subgroup analysis has shown a slightly statistically significant
difference in males.172
Considering the lack of hard data on the intensities generated by modern systems
and their potential for causing biological effects, perhaps the FDA should keep
ultrasound systems classified as prescription medical devices, until more information and
experience is gathered. Clearly, many of the previous clinical studies were performed at
intensities that may be inapplicable to most modern ultrasound systems, and many of
these early studies were on animal, not humans, and many existing epidemiological
studies have methodological flaws.173 These issues alone should support further FDA
enforcement of the current regulations, and unfettered scanning should be avoided until
more studies are done.174
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IV. Worldwide Medical Organizations Promulgate Polices Favoring Safety.
Worldwide organizations, such as The World Federation of Ultrasound in
Medicine and Biology (WFUMB), the Australian Society of Ultrasound in Medicine
(ASUM), and the European Federation of Societies for Ultrasound in Medicine and
Biology (EFSUMB), have issued policy statements regarding the safe use of ultrasound,
but they also have advised caution.175 All of these organizations have recognized the
potential for biological effects created by modern ultrasound systems.176 For example, the
WFUMB recommends that scanning time be kept as short as possible and the output
should be controlled so power levels will be low, but sufficient to obtain “diagnostic
information.”177 The ASUM also has emphasized the use of care, where it has
recommended the prudent use of ultrasound during examinations through adherence to
the ALARA principle to minimize exposures.178 It, too, recognizes that the current FDA
regulatory limit, which is set at the 720 mW/cm2 (ISPTA) maximum, may lead to
temperature increases greater than 2°C.179 Moreover, ASUM emphasized that “users”
must appreciate the design of their equipment, and they must realize that the indexes of
the ODS may not accurately predict the conditions at the tissue level during scanning.180
More importantly, EFSUMB stated that modern equipment is subject to output
regulation, but they also noted that their statements were only recommendations.181 If the
major world ultrasound organizations recognize the need for caution and advise prudence
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in the use ultrasound, then it should be no surprise that their American counterparts
express opposition to the non-medical uses of ultrasound.
IV. A. American Medical Organizations Also Favor Prudent Uses of Ultrasound.
The major medical associations and many of the technical and medical
organizations responsible for policies related to the use of diagnostic medical ultrasound
have called for the prudent use of this technology to gather diagnostic information. The
American Institute of Medicine and Biology has published an official statement regarding
the need for the “prudent use” of diagnostic medical sonography182 even though it
considers it safe.183 The “prudent use” standard has been recognized by the American
College of Obstetricians and Gynecologists (ACOG).184 The American College of
Radiology (ACR) Practice Guideline for diagnostic ultrasound studies recommends that a
diagnostic ultrasound should be supervised by a physician, obtained for a valid medical
reason, and performed at lowest levels possible.185 The Society of Diagnostic Medical
Sonography (SDMS) in its practice guidelines recommends that its members, as
ultrasound technologists (operators), “adhere to the standards, polices, and procedures
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adopted by the profession and regulated by the law.”186 The likely primary goal of all
organizations and their recommendations is the promotion of patient safety. More
importantly, all of these organizations have understood that the potential biological
effects exist and they have now opposed the non-medical uses of this technology.
IV. B. American Organizations Oppose Fetal Keepsake Imaging.
The same societies and organizations have addressed the issue of nonmedical uses
of diagnostic medical sonography to acquire “keepsake” fetal images. The AIUM issued
a new statement on August 1, 2005, on the use of “fetal keepsake” imaging, where it
recommended that “licensed medical professionals (either physicians or registered or
eligible sonographers) who have received specialized training in fetal imaging” perform
these studies.187 These professionals should have a working knowledge of medically
important conditions and be able to distinguish imaging artifacts from normal and
abnormal pathology.188 The AIUM further stated that “Any other use of ‘limited medical
ultrasound’ may constitute the practice of medicine without a license.”189
The American Medical Association has also expressed its disapproval by adopting
the FDA policy that recognizes “keepsake” fetal videos as an “unapproved use of a
medical device.”190 Its House of Delegates had urged the FDA to take action against this
use.191 The ACR in its practice guidelines related to obstetrical ultrasound also takes the
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position that “keepsake” fetal imaging is an unapproved use.192 Moreover, the SDMS (an
organization responsible for registering diagnostic medical sonographers) published its
position statement on this issue in 2004 opposing “the use of ultrasound solely for
entertainment purposes.”193 It would seem that the law, guidelines, and position
statements would fetal “keepsake” imaging, but it continues.
IV. C. Consumer Driven Self-Referral May Not Be Backed by Science.
Many of the issues related to companies that perform fetal “keepsake” imaging
also apply to the entrepreneurs who solicit consumers for these self-referred ultrasound
screening studies.194 Carotid ultrasound and heel ultrasound are only two of the many
ultrasound-based studies that have been used to screen patients.195 For any study to be an
effective screening study, the study must have a relatively high positive predictive value,
and the prevalence of the disease within the population screened must also be high.196
Some authors believe the prevalence of disease within the given population must
approach twenty percent for any screening study to be effective.197 As shown below
neither carotid nor heel ultrasound will meet these two criteria for screening.
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IV. C.1. Epidemiological Support May Be Lacking for Some, But Not All
Ultrasound Screening Studies.
In the case of carotid ultrasound, the goal of screening is to detect patients with
carotid stenosis that is greater than fifty percent, and to select patients who will benefit
from remedial measures, such as carotid endarterectomy.198 The estimated prevalence of
greater than fifty percent carotid stenosis within the general population may lie
somewhere between two and eight percent.199 The best sensitivity achievable with a
modern ultrasound systems approaches ninety-five percent for detecting a greater than
fifty percent stenosis, so the best positive predictive value for detection of disease within
the general population would approach fifty percent.200 Because the reported sensitivity
and specificity for modern color and pulsed Doppler systems is, generally, less than
ninety five percent, both the positive and negative predictive values would also be less
than fifty percent.201 Therefore, these predictive values would be too low to qualify
ultrasound as a screening study for carotid disease in an asymptomatic population.202 Not
only is this situation likely to lead to some patients receiving unwarranted studies and
interventions, it may not be cost-effective based on the quality of life adjusted years
achieved for this group of patients.203
Notwithstanding the current body of literature questioning the use of carotid
ultrasound for screening of asymptomatic patients, some authors do believe that these
patients can be screened in a cost-effective fashion with power Doppler (utilizing signal
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strength displayed in color rather than speed and direction).204 Because the predictive
value is low, the use of carotid ultrasound to screen patients for asymptomatic stenosis in
the general population remains questionable, and more research is needed to resolve the
controversy.205
The same may be said for the use of heel ultrasounds to screen women at low risk
for osteoporosis where the prevalence of the disease is estimated at six percent.206 The
current sensitivities reported for heal ultrasound are reported to vary from sixty to eighty
two percent.207 Moreover, the low prevalence of disease within the population screened
coupled with the low sensitivity of heal ultrasound could lead to some women with
osteoporosis being falsely reassured that they have a normal bone density.208 Thus, heal
ultrasound screening, as well as carotid ultrasound, may not be inappropriate for use in
the general population. Even so, mobile ultrasound screening companies exist in forty
three states. Internet services are now available that will match people with providers of
self-referred screening studies.209
IV. C. 2. Major Medical Organizations Question the Use of Ultrasound for
Routine Screening.
In June 2003, the AIUM issued an official statement that ultrasound screening of
asymptomatic patients had “no proven benefit,” and that more research was needed to
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establish the efficacy of these studies.210 The United States Preventive Services Task
Force did not recommend ultrasound screening for carotid disease.211 The same
organization only recommends ultrasound screening for abdominal aortic aneurysms
related to atherosclerotic disease in men who have ever smoked.212 The American
Academy of Family Physicians recommends against using Doppler or duplex ultrasound
to screen patients who are asymptomatic for peripheral arterial disease.213 The clinical
benefits of screening of asymptomatic patients with carotid ultrasound are unproven, and

the potential exists for falsely labeling people as “unhealthy,” which could lead to more
invasive studies.214
Others may use the test results as a reason not to alter their potentially deleterious
lifestyles.215 Moreover, health insurers generally do not cover these sorts of screening
studies, which means the “purchaser” covers its cost as an out-of-pocket expense.216
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Because some studies will lead to false positive results, additional studies will be required
that will necessarily drive up costs.217 The primary care physician and the healthcare
system may also incur “costs,” such as lost clinical time, especially when a primary care
physician must spend time explaining the unintended results of a self-referred screening
study to a dissatisfied consumer.218 Still, the rapid growth of the ultrasound screening
business continues to grow.219
V. Keepsake Imaging Companies May Be Violating Federal Drug Laws.
A recent survey for “keepsake” fetal imaging services advertising on the internet
revealed multiple “hits” for such businesses as 4D Sonograms in San Diego, CA; First
Glimpse in Baton Rouge, LA; Clearview Ultrasound in Austin, TX; Fetal Fotos in Frisco,
TX; Womb with a View in Arlington, TX, and Baby Insight in Potomac, MD.220 Most, if
not all, of these facilities have websites that advertise their use of registered diagnostic
medical sonographers (board certified) to perform all keepsake imaging studies, and they
also utilize the most modern ultrasound imaging systems available221 At least two,
keepsake imaging companies, Clearview and Baby Insight, have claimed that their
technologists perform studies with the modern, GE Voluson 730 “Pro” or “Expert”
systems, which are, as advertised, “top-of-the-line” systems.222 Because all of these
companies must vie for the same set of consumers, it should be no surprise that they all
217
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employ the latest technologies, have registered diagnostic medical sonographers, and
claim that ultrasound technology is safe, almost risk free.
Some of these companies further distinguish themselves from their competition
by making additional claims suggesting that their customers need not obtain a
“physician’s prescription” or a “note” before purchasing one of these studies. If one
surveys the Internet for postings, one will “hit” businesses, such as My Baby’s
Utrasound.com223 and BabiesPics.com,224 which may claim that they do not require a
note, while other businesses either do not make any claims, or make claims cover a range
of options.225 Some businesses, such as First Look Sonogram, expressly state that they do
require a note from a physician before they will perform one of these studies.226 Still
others recommend that anyone requesting one of these studies should obtain a prenatal
diagnostic ultrasound from their primary obstetrician and then discuss the options with
their physician before purchasing a fetal keepsake imaging study.227 The latter tactic
seems to shift the onus of decision making from the service provider to the consumer and
223
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her primary physician, while allowing the service provider to opt out of the decisionmaking process.
Yes, the variation in the number of claims made by the owners of these businesses
is vast, and it also illustrates just how difficult it may be for regulatory agencies to
monitor them and enforce regulations against them. The companies that claim they
deliver their services without a physician prescription, and do deliver them without a
physician being involved in the loop violate at least one regulation.228 They may also be
violating one or more additional safety regulations that flow from their lack of physician
involvement.229 For example, the company who violates the regulation requiring a
prescription or note from a referring physician, may violate additional regulations, such
as section 801.109(b)(1) which requires the posting of a cautionary statement on the
ultrasound system related to usage by a licensed physician.230 It may also misbrand the
device, since it did not require a prescription from a physician, but it may, or may not
adulterate the ultrasound device.231 Unfortunately, effective enforcement by the FDA
requires that it both discover potential violators, and prosecute them, and thus far, the
FDA has not closed one of these businesses down.232
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Regulation of these devices by the FDA may be further complicated by its
traditional stance of noninterference with respect to state regulation, especially where it
encroaches on the practice of medicine or pharmacy within a given state.233 Operators of
keepsake imaging services or ultrasound screening services often claim that they are not
breaking any regulations, because they are not performing diagnostic services.234 Some
states, however, are beginning to take action by creating state-based regulations to control
the distribution and use of ultrasound technology.
V. A. Nonmedical Uses of Ultrasound May Violate Multiple State Laws.
In 2003, some operators confessed their desire for more regulatory guidance from
the states, where they have their businesses and provide these services.235 Apparently,
some states have heeded their call for state-based regulatory guidance and intervention,
but the mechanisms states are pursuing do vary. Even so, the results have been mixed
with some states fairing better than others.Texas began enforcing its laws against these
facilities as early as 1996.236 In Texas, the Department of Health Services (TDHS), under
the Chapter 431 titled the Texas, Food, Drug, and Cosmetic Act (“TFDCA”), has the
authority to adopt the Federal Food, Drug, and Cosmetic Act and make the rules.237 It
also has the authority to monitor Texas businesses who may not comply with 21 C.F.R. §
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884.2225(a) and (b) in their use a Class II device,238 which requires a written or oral
authorization from a physician prior to its use.239 Because these devices are classified as
prescription devices, they cannot have adequate directions for lay use.240 They are also
exempted from the requirement for directions in their use, because they must be in the
possession of a physician.241 Not only do these devices fall come under the FFDCA, but
also they are under the Texas Food, Drug, and Cosmetic Act (“TFDCA”).242 The Texas
Act follows the same federal classification and regulatory scheme . If any Texas company
uses an ultrasound system or “device” without a “note,” it violates federal regulations,
and under the “TFDCA,” the company also “adulterates”243 and it “misbrands” the
“device.”244 It would seem relatively easy for a regulatory agency to match violators with
the appropriate regulatory violations, but a case adjudicated by Texas demonstrated just
how difficult prosecution of a violator can be.245
In that case, the State of Texas sued Ms. Erma Rayford and her business, Baby
Images, Inc., in 1996 for performing ultrasound scans on fetuses and providing videos to
consumers without a prescription from a physician.246 The suit was brought after the
TDHS cited Ms. Rayford on multiple occasions for performing these services without a
238
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physician prescription, or physician supervision.247 The State alleged that keepsake
imaging with an ultrasound device qualified as a “new intended use,” which moved the
device from Class II to Class III.248 As a Class III device, the State claimed that the
owner adulterated the device because the device did not receive premarket approval from
the FDA.249 Because the State viewed keepsake imaging as a new, intended use, it also
claimed that the owner had adulterated the device under the Texas Act.250 The State then
alleged that the company misbranded the device by not properly labeling it.251 A device
may be misbranded if it is a restricted device that is used without a physicians
prescription.252 Although not specifically addressed in the aforementioned case, the
TFDCA does not treat a registered diagnostic medical sonographer as a physician253 nor
does it qualify them as a practitioner.254 If a company violates one of these sections and
definitions, it then violates Chapter 483 (Dangerous Drugs) of the Health and Safety
Code.255

247

See id.
See id. at 206.
249
See id. at 207.
250
See TEXAS HEALTH & SAFETY CODE ANN. § 431.111 (Vernon 2003).
251
See Rayford, 16 S.W.3d at 210 (citing section 431.112(f)(1) and (r) of the Texas Health and Safety Code
Annotated as indicating misbranding may occur through improper labeling or unapproved use of a device).
252
See id. (citing section 431.112(r) of the Texas Health and Safety Code Annotated § 431.112(r)
determining that a device is misbranded if the device is used in violation of 21 U.S.C.S § 360j(e), where a
restricted device may be used only under the written or oral authorization of a physician).
253
See Medical Practice Act, TEXAS OCC. CODE ANN. § 151.002(12) (Vernon Supp. 2005) (“Physician”
means a person licensed to practice medicine in this state.).
254
See Texas Dangerous Drug Act, TEXAS HEALTH & SAFETY CODE ANN. § 483.001(12) (Vernon Supp.
2005) (“Practitioner means a person licensed: (A) by the Texas State Board of Medical Examiners, … to
prescribe or administer drugs; … (B) an advanced practice nurse or physician assistant to whom a
physician delegated the authority to carry out or sigh prescription drug orders … ”, but the Code does not
mention a registered or unregistered diagnostic medical sonographer.)
255
See Texas Dangerous Drug Act, TEXAS HEALTH & SAFETY CODE ANN. § 483.041 (Vernon Supp. 2005)
(defining the possession of dangerous drug as (a) “A person commits an offense if the person possesses a
dangerous drug unless the person obtains the drug from a … practitioner acting in the manner described by
Section 483.042(a)(2).”).
248

42

The State in Rayford also pursued a false advertising claim as well as a claim
under its Deceptive Trade Practices Act.256 The trial court found that a business, who
advertises that it does not require a note from a physician prior to the acquisition of an
ultrasound in its advertising violated TFDSA section governing the false advertisement of
a device, although the appellate court in Rayford found otherwise.257 Advertising for the
purposes of the TFDSA is “deemed to be false,” if it is false or it is “misleading in any
particular,” and the appellate determined that law applied to the seller, rather than the
owner or operator of a scanning business258 Thus, Ms. Rayford was able to escape a civil
fine or criminal proceedings brought by the attorney general or local officials.259 Because
the State believed she falsely advertised her services, then she also violated the Texas
Deceptive Trade Practices Act (TDTPA).260
In Rayford, the State alleged that a business,who falsely advertises that no
physician prescription is needed also violated the TDTPA.261 Under the Act, Baby
Images, Inc. violated the Act when it failed to disclose information for its goods or
services, which was also intended to induce a consumer to participate in a transaction it
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would not have had it been made aware of the information.262 Although the State was
granted summary judgment on this point at the district court level, the appellate court
found that the trial court erred, because State did not meet its burden as a matter of
law.263 In fact, the State had failed to present evidence to show that a mother would not
have purchased keepsake imaging services had she been made aware of the need for a
physician prescription.264 By winning on this point, Ms. Rayford and her business were
able to avoid summary judgment and a permanent injunction against performance of
keepsake imaging services based upon violation of the TDTPA.
Although the State ultimately received injunctive relief based on its misbranding
claim, it might have preferred a successful outcome on its DTPA claim. If the State had
won its claim, then it would have received additional advantages under the TDTPA.265
Not only could the State ask for injunctive relief from the practice, but also it could
request a civil fine be levied against the offending business.266 Civil fines may range from
$20,000 up to $250,000, depending on the offense and the particular consumer
involved.267 If a consumer suffers some documented harm or injury from one of these
studies, and it is also shown that the harm is a producing cause of injury, then the
consumer may be entitled to actual damages from the business.268 A business that violates
one or more sections of the Act could face substantial penalties. Even so, the result in the
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Rayford case demonstrates just how difficult it may be for a State to succeed in the
prosecution of its claims.
V. B. Ultrasound Without a Physician May Violate State Medical Practice Acts.
Although the federal government and many states, including Texas, want more
physician involvement, especially when it comes to fetal keepsake imaging, it may not be
easily achieved under the existing drug or device regulations. Some professional
organizations as well as states, such as Louisiana, are attempting to put these practices
within the scope of medical practice. For example, the Practice Guidelines promulgated
by the ACR state that ultrasound studies should be “performed by a qualified and
knowledgeable physician and/or sonographer using appropriate equipment and
techniques.269 The Society for Diagnostic Medical Sonographers (a society that licenses
or registers diagnostic medical sonographers or technologists) also addressed this issue in
their Diagnostic Ultrasound Clinical Practices Standards, where it stated that the
“Diagnostic Ultrasound Professional: 1.6.5 Provides an oral written summary of
preliminary findings to the interpreting physician.”270 The AIUM has also gone one step
further by declaring that it proscribes the practice of “limited medical ultrasound” or
“keepsake” imaging, where it relates to the performance of fetal imaging. Moreover, the
AIUM now views performance of such studies without a physician as the “practice of
medicine without a license.”271 This statement underscores the importance of the
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physician, but it also raises the possibility for an additional state cause of action through
the unlawful or unauthorized practice of medicine.
Although it would seem reasonable for a state to consider the performance of
diagnostic medical ultrasound as the practice of medicine, the definition of the practice of
medicine controls for the given state. Unfortunately, medical practice acts of the various
states may define the practice of medicine in either broad or narrow terms.272 Some states
may adopt a broad statement of the practice of medicine where “practice” may include a
“condition, physical or mental, real or imaginary.”273 Many jurisdictions include the term
“condition,” which may be so broadly defined as to include any state of human health or
disease.274 For example, California, the only state that has a statute specially directed
toward “keepsake” imaging, classifies a normal pregnancy as a “physical condition,” not
a disease.275 So, any nonphysician caring for a normal pregnancy would constitute the
unauthorized practice of medicine.276 Even with this broad definition of pregnancy, it
remains unclear whether California views the sonographers performing “keepsake” fetal
imaging as violating the practice of medicine.
Louisiana is one state with a fairly broad definition of the practice of medicine277
that has addressed the issue of self-referred diagnostic medical screening. In 2000, the

ultrasound scanning that may mimic pathology, and techniques to avoid ultrasound exposure beyond what
is considered safe for the fetus. Any other use of “limited medical ultrasound” may constitute practice of
medicine without a license. The AIUM reemphasizes that all imaging requires proper documentation and a
final report for the patient medical record signed by a physician.”).
272
See Lori B Andrews, The Shadows Health Care System: Regulation of Alternative Health Care
Providers, 32 HOUS. L. REV. 1273, 1299 (1996), available at http://lexis.com.
273
See Andrews, supra note 270, at 1299-1300.
274
See Andrews, supra note 270, at 1299.
275
See Andrews, supra note 272, at 1299.
276
See Andrews, supra note 272, at 1299.
277
See LA. REV. STAT. ANN. § 37:1262 (LexisNexis 2005) (“The practice of medicine … means holding
out of one’s self to the public as being engaged in the business of, or the actual engagement in, the
diagnosing, treating, curing, or relieving of any bodily or mental disease, condition, infirmity, defect,
ailment, or injury in any human being other than himself ….”).

46

Louisiana State Board of Medical Examiners (the “Board”) addressed the issue of
businesses practicing screening vascular ultrasounds (carotid ultrasound, peripheral
vascular ultrasound, and aortic ultrasounds for screening) in the state without the
involvement of a physician.278 The Louisiana Practice Act reads “the ‘practice of
medicine’ explicitly encompasses ‘the examining, either gratuitously or for
compensation, of any person … Whether such drug, instrument, force, or other agency or
means is applied to or used by the patient or by another person,’ for the purpose of
diagnosing a bodily or mental condition.”279 Based on the interpretation of the Act, the
“Board” sought action against those other than a licensed physician that performed selfreferred screening ultrasounds.280 The “Board” took this position based on its concern for
public safety, where the State did not have authority to regulate “ultrasound
technicians.”281 It also expressed its concern for the potential for misdiagnosis and patient
confusion based on inaccurate results.282 The “Board” also mandated that studies should
be supervised by a physician, not interpreted by the screening study, obtained by
physician referral, and performed with quality systems.283 Currently, any unlicensed

278

Louisiana State Board of Medical Examiners, Statement of Position, Self-Referred Diagnostic
Ultrasound Screening, available at http://www.lsbme.org/documents/ position
statement/UltrasoundScreening.pdf.
279
See Louisiana State Board of Medical Examiners, Statement of Position, Self-Referred Diagnostic
Ultrasound Screening, supra note 280.
280
See Louisiana State Board of Medical Examiners, Statement of Position, Self-Referred Diagnostic
Ultrasound Screening, supra note 280.
281
See Louisiana State Board of Medical Examiners, Statement of Position, Self-Referred Diagnostic
Ultrasound Screening, supra note 276.
282
See Louisiana State Board of Medical Examiners, Statement of Position, Self-Referred Diagnostic
Ultrasound Screening, supra note 276.
283
See Lousiana State Board of Medical Examiners, Statement of Position, Self-Referred Diagnostic
Ultrasound Screening, supra note 276.

47

personnel that performs these types of studies becomes subject to an injunction and/or
criminal sanctions.284
Enforcement actions similar to those taken by the Louisiana State Board of
Medical Examiners may be more problematic for those states, such as Texas, who have
rather narrow definitions of medical practice. For example, the Texas Occupation Code
defines the practice of medicine as “the diagnosis, treatment, or offer to treat a mental or
physical disease or disorder or physical deformity or injury by any system or method, or
the attempt to effect cures of those conditions, by person who (A) publicly professes to be
a physician or surgeon; or (B) directly or indirectly charges money or other compensation
for those services.”285 Where the Texas State Board (TSB) lacks jurisdiction to enforce
actions for the unlicensed practice of medicine, the Code contemplates the attorney
general or other officials making investigations and handling prosecutions, or seeking
injunctive relief.286 Unfortunately, the Code uses more restrictive language than the
Louisiana statute, because Texas focuses on the “mental or physical disease or disorder or
a physical deformity or injury.” The Code does not define either the term “disease” or
“disorder.”287 Based on the plain meaning of the term disease,288 it refers to “pathological
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conditions.”289 It is unlikely that those performing keepsake ultrasound imaging would
ever be considered practicing medicine unless the person made a diagnosis of a
pathological condition that led to treatment. The language of the Code is likely too
narrow to characterize these practices as the unlawful practice of medicine.
This may not be the case for individuals who perform self-referred ultrasound
screening studies for peripheral disease. Vascular ultrasound studies such as carotid
ultrasound, peripheral vascular ultrasound, and aortic ultrasound for aorta aneurysm are
performed to diagnose disease.290 The very purpose of these studies is to screen for
disease. If any of these screening studies are done by a sonographer without having a
physician in the loop, it is hard to envision how any report could be issued that would not
violate the unlawful or unauthorized practice of medicine. Where no physician is
involved, technologists who perform an ultrasound screening study could be holding
themselves out as a physician to the public, where the ultrasound system has the
cautionary statement mandated by the FDA for use by a “physician” posted on it. The
technologist need not publicly profess that he or she is a physician.291 The very nature of
the activities that person does may be sufficient to hold oneself out to be a physician.292
In Weyandt v. The State of Texas, the Fourteenth Court of Appeals upheld the
conviction of a nurse anesthetist for the unlawful or unauthorized practice of medicine
289
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where she never publically professed that she was a “physician.”293 She was charged and
convicted of the unauthorized practice of medicine stemming from incident where she
saw an “undercover” police officer for an alleged shoulder injury. The defendant told the
undercover officer she was a “doctor,” but she never said she was a physician or licensed
to practice medicine in Texas.294 She did possess a degree in medicine from a university
in Mexico, and she was a Certified Registered Nurse Anesthetist (CRNA), an advanced
nurse practitioner, and a certified hypnotherapist. She also had a sign on her office door
stating “Dr. Linda J. Weyandt,” and her office looked like the office of a doctor. She
proceeded to attached wires from a peripheral nerve stimulator to the allegedly injured
shoulder of the investigator. During the process of stimulation, the investigator
experienced some mild pain and muscle twitching. An expert witness at her trial testified
that a peripheral nerve stimulator was a diagnostic, not therapeutic device. In addition to
the nerve stimulation, the defendant tried to hypnotize the investigator, and she also gave
the investigator some herbal tea to drink.295 Based on these facts, the court upheld her
conviction for the unauthorized practice of medicine.296
The court noted that the lack of credentials by the defendant was not the problem,
but her failure to hold a valid license to practice medicine in Texas.297 The court
explained that the defendant need not make any affirmative representation that she was a
medical doctor, a physician, or a surgeon to violate the Act.298 Moreover, a defendant
may violate the Act by the very nature of “what one does, and not only what one says

293

See id.
See id. at **14.
295
See id. at **4.
296
See id.at **19.
297
See id. at **19.
298
See id. at **12.
294

50

they are doing, to determine whether they are practicing medicine.”299 The court
concluded, based on the facts presented at trial, that the defendant “implicitly suggested”
she was physician, when she purported to diagnose and treat the investigator.300 Thus, the
court was not swayed by the testimony of the expert regarding the lack of known
therapeutic uses of a peripheral nerve stimulator.
Based on the statements by the court in Weyandt, a sonographer need not
specifically state he or she is a physician to practice medicine without a license. Texas
sonographers who perform diagnostic medical ultrasound screening studies could be
practicing medicine without a license, where they issue a report rendering a diagnosis of
a disease process, such as atherosclerosis or osteoporosis. Not only may these
sonographers be practicing medicine without a license, but they may also be violating
federal regulations that require posting of a statement that the FDA “restricts this device
to sale by or on the order of a physician or other licensed practitioner” under laws of the
state.301 As in the Weyandt case, such a notice or sign on the ultrasound, if seen by a
patient, could, in theory, be treated as a representation that the technologist performing
the scan is a physician. Certainly, the device user facility, as any other clinic or physician
office, could easily lead a patient to believe that a technologist performing ultrasound
could be a physician. Thus, it seems that Texas State Board could, in those cases
involving self-referred screen studies, seek assistance from the attorney general or local
authorities to pursue the unauthorized or unlawful practice of medicine. Ultimately, it
may well be a question of fact for a judge or jury to determine.
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V. C. Successful Regulation May Require a Collaborative Effort Between the
State Legislatures and Professionals.
If the parties participating in the process of diagnostic medical ultrasound
behaved reasonably, then perhaps, regulatory interventions would be unnecessary.
Unfortunately, some people, such as Tom Cruise or ultrasound imaging entrepreneurs, do
not always recognize or honor what others might consider as reasonable behavior.
Perhaps, the best approach to controlling the use and potential misuse of diagnostic
medical ultrasound might reside in a collaborative effort between all stake holders in the
process.
It has been demonstrated throughout this article that the FDA as well as various
state agencies may not be capable of effectively regulating these practices. After all,
effective regulation often requires cooperation from all participating parties. The ultimate
solution to the problem may require a collaborative effort between all parties including
state legislatures, branches of government responsible for enforcing regulations, medical
societies, owners and technicians of the ultrasound facilities, and consumers. Based on
recent events, total cooperation among the stake-holders is highly unlikely, but steps can
be taken to ensure consumer safety without enacting overly restrictive regulations.
The first step in bringing reason back to the current dynamic will require the
legislatures of the several states to follow the path of California, and draft sensible
legislation that specifically regulates the ability of non-medically trained consumers to
purchase or operate these devices.302 By controlling distribution of these sophisticated
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medical systems at the level of the manufacturer, legislatures will address the supply side
of the equation by limiting who may purchase these systems. Such legislation will keep
both cart-based and HCDs out of the hands of untrained individuals,303 even if individuals
including Tom Cruise, have the financial means to purchase them. It will also serve as a
brake on manufacturers who may be willing to sell their systems to untrained consumers
to boost their profit margins. By controlling manufacturers who are willing to sell to
anyone with the dollars to buy, it will force all parties to play by the existing rules.
If all states legislatures will follow the lead of California by drafting legislation
that put physicians into the loop, as either buyers or providers, then states will foster
access to qualified individuals. More importantly, consumer safety will likely be
enhanced, because physicians will become responsible for quality control and monitoring
technical performance. This arrangement could serve to initiate a system of checks-andbalances, where both physicians and diagnostic medical sonographers must adhere to the
ALARA and ODS principles. This dynamic will offer consumers the opportunity to be
scanned under the safest conditions possible without overly restricting their access to
ultrasound imaging opportunities. Although the California Senate Health Committee has
yet to formally pass this Bill, it has recently voted to recommend passage of the Bill,
which is certainly a step in the right direction.304
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Next, medical societies must rethink their position on the practice of fetal
keepsake imaging, where current policies frown or dissuade physicians and mothers, as
willing consumers, from participating in these studies. As this article has pointed out, the
current regulations and policies are not entirely successful, and it may be time for the
members of the medical societies to adopt a more flexible approach. Since many
physicians advocate fetal keepsake imaging for their patients in order to increase
bonding, while others cite medical and biological safety reasons for opposing it, the time
may have arrived for all parties to seek out a common ground. The goal should be to
interject more physician involvement, not less. More importantly, the societies that
control diagnostic medical sonographers should adopt regulations that would either
restrict or revoke the licenses of technologists who perform ultrasound studies without
either a supervising of physician or an order from a physician. Such regulations should
not be so restrictive that it would alter current medical practices, where technicians

perform studies that are reviewed and interpreted by a physician at a later time.305 The
key here is not to so alter current practice that it chokes off access of consumers to
ultrasound imaging services or creates unnecessary delays. On the contrary, physicians
specializing in ultrasound should work with diagnostic medical sonographers to create
referral networks so consumers can have greater access to imaging, but under controlled
conditions.
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Because many physicians and consumers view keepsake imaging studies as part
of a nondiagnostic, bonding experience, sonographers should perform these studies only
if a physician is in-the-loop, that is—a physician has ordered these imaging experiences
after a formal diagnostic study. By meeting the latter step, sonographers may avoid
potential violations of state and federal regulatory laws. A still better approach would
have physicians trained in diagnostic ultrasound offering keepsake imaging experiences
to their patients as part of the standard obstetrical imaging experience at a nominal charge
to patients who want the experience. Of course, clinical practices will have to upgrade at
least one of their imaging suites to mirror the theater-like experience. Yes, it will require
a capital expense, but such an expense might be offset by the revenues from patients who
wish to purchase the experience, and from its potential of these services to attract new
patients from the family and friends who feel and see the experience. Moreover,
endorsement of this practice by major medical organizations will ensure that physicians
are involved from the very beginning of the process. Great involvement and oversight
should alleviate many of the medical and ethical issues currently raised by the practice of
keepsake imaging. Greater physician involvement will also serve to legitimize the
process, and it will likely lead to further investigational studies, which could help resolve
the current debate related to the potential biological effects of ultrasound scanning and
bonding benefits.
Finally, medicine needs to do a better job of evaluating medical imaging as it is
applied to screening studies. Again, the goal of any regulatory control scheme should be
to curb waste, fraud, and abuse, not encourage it. Unfortunately, the dynamic of self-

55

referral is ripe for abuse by physicians.306 Although Medicare may not pay for consumer
driven imaging studies done to screen for diseases, some are concerned that these
practices may also contribute to over-utilization of imaging services.307 Still others point
out that “scan all” strategies in certain patient groups may actually decrease rather than
increase the overall costs of care.308 Nevertheless, all agree some form of control may be
necessary, which is best achieved through a collaborative effort at all levels.309
The process should begin, as in California, with states passing laws to control the
supply-side of the technology in order to limit its access to untrained or unqualified
personnel. Next, medical societies and medical boards should take affirmative action,
similar to those taken by the Louisiana State Board Medical Examiners, to bring selfreferral screening studies and those who perform them under their medical practice acts.
Moreover, medical societies that govern the behavior of diagnostic medical sonographers
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should also support their local medical boards by becoming more aggressive in policing
the actions of their constituents. More importantly, medical societies should encourage
medical educators and researchers to do more evidence based analysis of screening
studies, especially in areas related to diagnostic medical imaging. Unfortunately,
effective regulatory control may also require participants to notify the appropriate
agencies of the existence of potential violations. Until all the parties come together to
formulate an acceptable policy, it is unlikely that current practices are going to change in
the near future.
VI. Conclusion.
In closing, it is important for everyone to recognize that diagnostic medical
ultrasound is now, and always will be, a very powerful diagnostic tool in the right hands.
Patient safety should always be the primary focus of any attempt to regulate the use of
ultrasound devices. Although ultrasound is currently recognized as a safe technology, the
preexisting animal and epidemiological studies may not be sufficiently complete to draw
definitive conclusions about the current energies utilized by modern systems, especially if
individuals are now exceeding the uses intended by the manufacturers. States should
support the FDA in its efforts to curb the abuses by aggressively enforcing federal and
state regulations to restrict use without physician involvement. States, where possible,
should also use their medical practice acts to ensure that physicians are brought into the
process. States that lack the necessary laws to control the unrestricted access of untrained
or unqualified individuals to these systems should follow the lead of California, and
begin enacting laws that will effectively control supply. No one questions the lucrative
nature of the ultrasound imaging market, and because it is so lucrative, it will likely
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continue to grow. It is only natural for manufacturers to further their economic
advantages by selling systems to willing buyers. Until sensible laws are enacted to check
current practices, patients will be at risk, where the unknowledgeable have access to
systems and perform scans that needlessly expose individuals to potentially harmful
biological effects. The problem is medicine does not truly know what the absolute risks
or biological hazards that may be associated with this technology, and until medicine
discovers them, caution is warranted. All parties should act responsibly by adhering to
the ALARA standard, until more studies have been conducted to affirm that ultrasound at
the newer energy levels is virtually risk free. Moreover, medicine needs to rethink its
policies, and consider adopting more flexible approaches to less conventional practices to
meet the needs of modern consumers. In the end, it should be the individual, as an
informed consumer, who should enjoy the medical benefits of this technology, not the
providers of nondiagnostic imaging services, who seek to entertain or just take advantage
of their clientele.
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